tiprankstipranks
Marizyme Incorporated (MRZM)
OTHER OTC:MRZM
US Market

Marizyme (MRZM) Financial Statements

4 Followers

Marizyme Financial Overview

Marizyme's market cap is currently ―. The company's EPS TTM is $-1.384; its P/E ratio is -0.04; Marizyme is scheduled to report earnings on December 23, 2021, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 32.85K$ 184.74K$ 128.97K$ 95.66K$ 76.01K
Gross Profit$ 23.21K$ 135.13K$ 89.70K$ -5.01M$ 60.51K
EBIT$ -1.48M$ -20.58M$ 2.39M$ -26.15M$ -742.04K
EBITDA$ -1.27M$ -20.37M$ 2.18M$ -25.73M$ -531.68K
Net Income Common Stockholders$ -6.23M$ -20.58M$ 1.97M$ -23.56M$ -1.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.15K$ 205.23K$ 359.81K$ 540.87K$ 1.18M
Total Assets$ 21.57M$ 36.98M$ 38.27M$ 38.69M$ 63.73M
Total Debt$ 23.56M$ 14.35M$ 7.03M$ 2.62M$ 3.44M
Net Debt$ 23.55M$ 14.15M$ 6.67M$ 2.08M$ 2.26M
Total Liabilities$ 32.40M$ 29.71M$ 23.04M$ 21.27M$ 22.78M
Stockholders Equity$ -10.83M$ 7.27M$ 15.23M$ 17.42M$ 40.95M
Cash Flow-
Free Cash Flow$ -808.95K$ -1.20M$ -1.12M$ -1.59M$ -2.21M
Operating Cash Flow$ -808.95K$ -1.20M$ -1.12M$ -1.59M$ -2.21M
Investing Cash Flow-----
Financing Cash Flow$ 666.63K$ 1.07M$ 939.10K$ 914.73K$ 1.35M
Currency in USD

Marizyme Earnings and Revenue History

Marizyme Debt to Assets

Marizyme Cash Flow

Marizyme Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis